Journal of Infection
Volume 61, Issue 3 , Pages 212-218 , September 2010

Impact of inappropriate antimicrobial therapy on outcome in patients with hospital-acquired pneumonia caused by Acinetobacter baumannii

  • Mi Kyong Joung

      Affiliations

    • Division of Infectious Diseases, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
    • ,
  • Ki Tae Kwon

      Affiliations

    • Division of Infectious Diseases, Daegue Fatima Hospital, Seoul, Republic of Korea
    • ,
  • Cheol-In Kang

      Affiliations

    • Division of Infectious Diseases, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
    • ,
  • Hae Suk Cheong

      Affiliations

    • Division of Infectious Diseases, Konkuk University Hospital, Seoul, Republic of Korea
    • ,
  • Ji-young Rhee

      Affiliations

    • Division of Infectious Diseases, Dankuk University Hospital, Seoul, Republic of Korea
    • ,
  • Dong Sik Jung

      Affiliations

    • Division of Infectious Diseases, Dong-A University Hospital, Seoul, Republic of Korea
    • ,
  • Seung Min Chung

      Affiliations

    • Division of Infectious Diseases, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
    • ,
  • Jeong A. Lee

      Affiliations

    • Division of Infectious Diseases, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
    • ,
  • Soo-youn Moon

      Affiliations

    • Division of Infectious Diseases, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
    • ,
  • Kwan Soo Ko

      Affiliations

    • Asian-Pacific Research Foundation for Infectious Diseases (ARFID), Seoul, Republic of Korea
    • ,
  • Doo Ryeon Chung

      Affiliations

    • Division of Infectious Diseases, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
    • ,
  • Nam Yong Lee

      Affiliations

    • Department of Laboratory Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Republic of Korea
    • ,
  • Jae-Hoon Song

      Affiliations

    • Division of Infectious Diseases, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
    • Asian-Pacific Research Foundation for Infectious Diseases (ARFID), Seoul, Republic of Korea
    • ,
  • Kyong Ran Peck

      Affiliations

    • Division of Infectious Diseases, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
    • Corresponding Author InformationCorresponding author. Tel.: +82 2 3410 0329; fax: +82 2 3410 0041.

,Accepted 24 June 2010.

References 

  1. Bouvet PJ, Grimont PA. Identification and biotyping of clinical isolates of Acinetobacter. Ann Inst Pasteur Microbiol. 1987;138:569–578
  2. Gaynes R, Edwards JR. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis. 2005;41:848–854
  3. Fagon JY, Chastre J, Domart Y, Trouillet JL, Gibert C. Mortality due to ventilator-associated pneumonia or colonization with Pseudomonas or Acinetobacter species: assessment by quantitative culture of samples obtained by a protected specimen brush. Clin Infect Dis. 1996;23:538–542
  4. Fagon JY, Chastre J, Hance AJ, Montravers P, Novara A, Gibert C. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med. 1993;94:281–288
  5. Garnacho-Montero J, Ortiz-Leyba C, Jimenez-Jimenez FJ, Barrero-Almodovar AE, Garcia-Garmendia JL, Bernabeu-Wittel IM, et al. Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. Clin Infect Dis. 2003;36:1111–1118
  6. Garnacho-Montero J, Ortiz-Leyba C, Fernandez-Hinojosa E, Aldabo-Pallas T, Cayuela A, Marquez-Vacaro JA, et al. Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings. Intensive Care Med. 2005;31:649–655
  7. Fagon JY, Chastre J, Domart Y, Trouillet JL, Pierre J, Darne C, et al. Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques. Am Rev Respir Dis. 1989;139:877–884
  8. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818–829
  9. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383
  10. Kwon KT, Oh WS, Song JH, Chang HH, Jung SI, Kim SW, et al. Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia. J Antimicrob Chemother. 2007;59:525–530
  11. Sunenshine RH, Wright MO, Maragakis LL, Harris AD, Song X, Hebden J, et al. Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis. 2007;13:97–103
  12. Seifert H, Strate A, Pulverer G. Nosocomial bacteremia due to Acinetobacter baumannii. Clinical features, epidemiology, and predictors of mortality. Medicine (Baltimore). 1995;74:340–349
  13. Choi JY, Park YS, Kim CO, Yoon HJ, Shin SY, Kim YA, et al. Mortality risk factors of Acinetobacter baumannii bacteraemia. Intern Med J. 2005;35:599–603
  14. Albrecht MC, Griffith ME, Murray CK, Chung KK, Horvath EE, Ward JA, et al. Impact of Acinetobacter infection on the mortality of burn patients. J Am Coll Surg. 2006;203:546–550
  15. Blot S, Vandewoude K, Colardyn F. Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study. Intensive Care Med. 2003;29:471–475
  16. Celis R, Torres A, Gatell JM, Almela M, Rodriguez-Roisin R, Agusti-Vidal A. Nosocomial pneumonia. A multivariate analysis of risk and prognosis. Chest. 1988;93:318–324
  17. Iregui M, Ward S, Sherman G, Fraser VJ, Kollef MH. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest. 2002;122:262–268
  18. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest. 1999;115:462–474
  19. Dupont H, Mentec H, Sollet JP, Bleichner G. Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia. Intensive Care Med. 2001;27:355–362
  20. Dupont H, Montravers P, Gauzit R, Veber B, Pouriat JL, Martin C. Outcome of postoperative pneumonia in the Eole study. Intensive Care Med. 2003;29:179–188
  21. Leroy O, Meybeck A, d’Escrivan T, Devos P, Kipnis E, Georges H. Impact of adequacy of initial antimicrobial therapy on the prognosis of patients with ventilator-associated pneumonia. Intensive Care Med. 2003;29:2170–2173
  22. Rello J, Vidaur L, Sandiumenge A, Rodriguez A, Gualis B, Boque C, et al. De-escalation therapy in ventilator-associated pneumonia. Crit Care Med. 2004;32:2183–2190
  23. Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis. 2006;42(Suppl. 2):S82–S89

PII: S0163-4453(10)00181-7

doi: 10.1016/j.jinf.2010.06.014

Journal of Infection
Volume 61, Issue 3 , Pages 212-218 , September 2010

Article Tools

* Image Usage & Resolution